SEC Form 4 · accession 0001213900-26-074187
YD Bio Ltd · YDES
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kochi Chang
Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 3:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002011674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 30, 2026 | M | 5,749 | — | A | 7,830 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF2,F3,F1 | — | Jun 30, 2026 | A | 5,749 | A | — | — | Ordinary Shares | 5,749 | 5,749 | D |
| Restricted Share UnitsF1,F2 | — | Jun 30, 2026 | M | 5,749 | D | — | — | Ordinary Shares | 5,749 | 0 | D |
Explanation of responses
- F1Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share, par value $0.0001 per share ("Ordinary Shares"), of YD Bio Limited.
- F2The RSUs were granted pursuant to the YD Bio Limited Equity Incentive Plan with an aggregate target grant date fair value of $60,000 on March 31, 2026 (the "Granted RSUs"). The Granted RSUs vest in four equal quarterly installments beginning March 31, 2026, with the number of RSUs subject to vesting to be determined on the applicable vesting date by dividing $15,000 by the seven (7) trading-day volume-weighted average price of the Company's Ordinary Shares ending on the trading day immediately prior to such vesting.
- F3The Reporting Person became entitled to a fixed number of RSUs on June 30, 2026 (the "Vesting Date").